Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
123423573 | 12342357 | 3 | F | 20160708 | 20160506 | 20160713 | EXP | CA-PFIZER INC-2016246328 | PFIZER | 72.00 | YR | F | Y | 0.00000 | 20160713 | MD | CA | CA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
123423573 | 12342357 | 1 | I | ENBREL | ETANERCEPT | 1 | Subcutaneous | 50 MG, QWK | U | 0 | 50 | MG | /wk | ||||||
123423573 | 12342357 | 2 | PS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Subcutaneous | 20 MG, UNK | U | 11719 | 20 | MG | SOLUTION FOR INJECTION | ||||||
123423573 | 12342357 | 3 | SS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Subcutaneous | 25 MG, UNK | U | 11719 | 25 | MG | SOLUTION FOR INJECTION | ||||||
123423573 | 12342357 | 4 | SS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Subcutaneous | 2.5 MG, UNK | U | 11719 | 2.5 | MG | SOLUTION FOR INJECTION | ||||||
123423573 | 12342357 | 5 | SS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Subcutaneous | 10 MG, UNK | U | 11719 | 10 | MG | SOLUTION FOR INJECTION | ||||||
123423573 | 12342357 | 6 | SS | CELEBREX | CELECOXIB | 1 | Unknown | UNK | U | 20998 | CAPSULE, HARD | ||||||||
123423573 | 12342357 | 7 | SS | SULFASALAZINE. | SULFASALAZINE | 1 | Unknown | 2 MG, UNK | U | 7073 | 2 | MG | |||||||
123423573 | 12342357 | 8 | SS | ARAVA | LEFLUNOMIDE | 1 | Unknown | UNK | U | 0 | TABLET | ||||||||
123423573 | 12342357 | 9 | SS | HYDROXYCHLOROQUINE | HYDROXYCHLOROQUINE | 1 | Unknown | 300 MG, UNK | U | 0 | 300 | MG | |||||||
123423573 | 12342357 | 10 | SS | LEFLUNOMIDE. | LEFLUNOMIDE | 1 | Oral | 10 MG, UNK | U | 0 | 10 | MG | TABLET | ||||||
123423573 | 12342357 | 11 | SS | ORENCIA | ABATACEPT | 1 | Subcutaneous | 250 MG, UNK | U | 0 | 250 | MG | POWDER AND SOLVENT FOR SOLUTION FOR INJECTION | ||||||
123423573 | 12342357 | 12 | SS | PREDNISONE. | PREDNISONE | 1 | Unknown | UNK | U | 0 | |||||||||
123423573 | 12342357 | 13 | SS | RITUXAN | RITUXIMAB | 1 | Intravenous (not otherwise specified) | UNK | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
123423573 | 12342357 | 1 | Rheumatoid arthritis |
123423573 | 12342357 | 6 | Arthritis |
123423573 | 12342357 | 8 | Arthritis |
123423573 | 12342357 | 9 | Rheumatoid arthritis |
123423573 | 12342357 | 10 | Rheumatoid arthritis |
123423573 | 12342357 | 11 | Rheumatoid arthritis |
123423573 | 12342357 | 12 | Arthritis |
123423573 | 12342357 | 13 | Rheumatoid arthritis |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
123423573 | 12342357 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
123423573 | 12342357 | Bone swelling | |
123423573 | 12342357 | Candida infection | |
123423573 | 12342357 | Condition aggravated | |
123423573 | 12342357 | Drug effect decreased | |
123423573 | 12342357 | Drug ineffective | |
123423573 | 12342357 | Drug interaction | |
123423573 | 12342357 | Joint swelling | |
123423573 | 12342357 | Local swelling | |
123423573 | 12342357 | Nausea | |
123423573 | 12342357 | Neoplasm malignant | |
123423573 | 12342357 | Oral candidiasis | |
123423573 | 12342357 | Pain | |
123423573 | 12342357 | Peripheral swelling | |
123423573 | 12342357 | Swelling | |
123423573 | 12342357 | Thyroid neoplasm | |
123423573 | 12342357 | Toxicity to various agents |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |